Cases & Deals

  • Home
  • Practices
  • Athersys issues $21 million of Common Stock in public offering

Share

Athersys issues $21 million of Common Stock in public offering

November 2012

Client(s) Athersys, Inc.

Jones Day advised Athersys, Inc., a clinical stage biopharmaceutical company, in connection with the issuance of $21 million of Common Stock in a public offering, underwritten by Piper Jaffray & Co. and First Analysis Securities Corporation.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.